CASI Pharmaceuticals, Inc.

CASI · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$4,685$6,740$10,897$13,468
Short-Term Investments$0$22$1,802$2,623
Receivables$2,609$5,363$7,600$15,345
Inventory$2,611$3,397$4,153$5,252
Other Curr. Assets$0$2,640$2,712$2,888
Total Curr. Assets$11,915$18,162$27,164$39,576
Property Plant & Equip (Net)$9,947$10,450$10,920$11,360
Goodwill$0$0$0$0
Intangibles$224$230$233$238
Long-Term Investments$1,716$1,716$1,914$1,716
Tax Assets$0$0$0$0
Other NC Assets$660$644$590$587
Total NC Assets$12,547$13,040$13,657$13,901
Other Assets$0$0$0$197
Total Assets$24,462$31,202$40,821$53,674
Liabilities
Payables$560$805$1,195$2,723
Short-Term Debt$18,855$18,734$18,492$18,385
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$2,474
Other Curr. Liab.$0$0$0$10,315
Total Curr. Liab.$39,421$37,737$33,713$36,452
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$13,633$13,775$15,178$12,836
Total NC Liab.$13,633$13,775$15,178$15,371
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$3,756
Total Liabilities$53,054$51,512$48,891$51,823
Equity
Pref Stock$0$0$0$0
Common Stock$2$2$2$2
Retained Earnings-$735,090-$724,200-$710,825-$700,075
AOCI-$5,138-$2,240-$2,228-$1,774
Other Equity$0$0$0$0
Total Equity-$28,592-$20,310-$8,070$1,851
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$24,462$31,202$40,821$53,674
Net Debt$14,170$11,994$7,595$4,917